Evidence map›Paper›PMID 37755502›Full record

ArticleArchives of toxicology2023

Analysis of health concerns not addressed by REACH for low tonnage chemicals and opportunities for new approach methodology.

Philip Botham, Mark T D Cronin, Richard Currie, John Doe, Dorothee Funk-Weyer, Timothy W Gant, Marcel Leist, Sue Marty, Bennard van Ravenzwaay, Carl Westmoreland

Open access · hybridAbstract read
In one paragraph

Article in Archives of toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Navigating complexity in modern toxicology: the role of omics in short-term in vivo studies.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Review
  3. Review
  4. A twin transition in regulatory toxicology: moving toward Chemicals 2.0 and phasing out animal testing.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 4 countries.

Philip BothamSyngenta Product Safety, Jealott's Hill International Research Centre, Bracknell, RG42 6EY, Berkshire, UK.
Mark T D CroninSchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK. m.t.cronin@ljmu.ac.uk.ORCID 0000-0002-6207-4158
Richard CurrieSyngenta Product Safety, Jealott's Hill International Research Centre, Bracknell, RG42 6EY, Berkshire, UK.
John DoeSchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK.ORCID 0000-0001-5393-1421
Dorothee Funk-WeyerBASF SE, Experimental Toxicology and Ecology, Carl-Bosch-Strasse 38, 67056, Ludwigshafen am Rhein, Germany.
Timothy W GantToxicology Department, Centre for Radiation, Chemical and Environmental Hazards, UK Health Security Agency, Harwell Science Campus, Chilton, OX11 0RQ, UK.ORCID 0000-0001-9057-4937
Marcel LeistDepartment of Biology and CAAT-Europe, University of Konstanz, 78457, Constance, Germany.ORCID 0000-0002-3778-8693
Sue MartyThe Dow Chemical Company, Toxicology and Environmental Research and Consulting, 1803 Building, Midland, MI, 48674, USA.ORCID 0000-0002-5404-8515
Bennard van RavenzwaayDepartment of Agrotechnology and Food Sciences, Wageningen University and Research, 6708 WG, Wageningen, The Netherlands.ORCID 0000-0002-4264-9217
Carl WestmorelandSEAC, Unilever, Colworth Science Park, Sharnbrook, MK44 1LQ, Bedfordshire, UK.
Liverpool John Moores University · GBSyngenta (United Kingdom) · GBBASF (Germany) · DEDow Chemical (United States) · USUK Health Security Agency · GBUnilever (United Kingdom) · GBUniversity of Konstanz · DEWageningen University & Research · NL

Funding

DK EPA MST-667-00205Horizon 2020 Framework Programme 825759Horizon 2020 Framework Programme 964518Horizon 2020 Framework Programme 964537Land-BW NAM-ACCEPT
6 · The paper itself

Abstract

In Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) the criterion for deciding the studies that must be performed is the annual tonnage of the chemical manufactured or imported into the EU. The annual tonnage may be considered as a surrogate for levels of human exposure but this does not take into account the physico-chemical properties and use patterns that determine exposure. Chemicals are classified using data from REACH under areas of health concern covering effects on the skin and eye; sensitisation; acute, repeated and prolonged systemic exposure; effects on genetic material; carcinogenicity; and reproduction and development. We analysed the mandated study lists under REACH for each annual tonnage band in terms of the information they provide on each of the areas of health concern. Using the European Chemicals Agency (ECHA) REACH Registration data base of over 20,000 registered substances, we found that only 19% of registered substances have datasets on all areas of health concern. Information limited to acute exposure, sensitisation and genotoxicity was found for 62%. The analysis highlighted the shortfall of information mandated for substances in the lower tonnage bands. Deploying New Approach Methodologies (NAMs) at this lower tonnage band to assess health concerns which are currently not covered by REACH, such as repeat and extended exposure and carcinogenicity, would provide additional information and would be a way for registrants and regulators to gain experience in the use of NAMs. There are currently projects in Europe aiming to develop NAM-based assessment frameworks and they could find their first use in assessing low tonnage chemicals once confidence has been gained by their evaluation with data rich chemicals.

Indexed as

ReproductionSkinEuropeHumansRisk Assessmentlow tonnage chemicalsNew Approach MethodologiesREACHRisk Assessment

Identifiers

PMID37755502
PMCPMC10567824
OpenAlexW4387077839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.